RBP2 and cancer: Others found that loss of the retinoblastoma binding protein 2 (RBP2) histone demethylase suppresses tumorigenesis in mice lacking Rb1 or Men1 and Sharma SV published data illustrating a chromatin-mediated reversible drug-tolerant state in cancer cell subpopulations [16, 17].